Alliance Global Partners Starts AcelRx Pharmaceuticals (ACRX) at Buy
Tweet
Share
E-mailGet Alerts ACRX Hot Sheet
Price: $0.86 --0%
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Rating Summary:
10 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Join SI Premium – FREE
Alliance Global Partners analyst James Molloy initiates coverage on AcelRx Pharmaceuticals (NASDAQ: ACRX) with a Buy rating and a price target of $4.25.
For an analyst ratings summary and ratings history on AcelRx Pharmaceuticals click here. For more ratings news on AcelRx Pharmaceuticals click here.
Shares of AcelRx Pharmaceuticals closed at $0.58 yesterday.
You May Also Be Interested In
- B.Riley Starts Weave Communications Inc (WEAV) at Buy
- BofA Securities Upgrades Americold Realty Trust (COLD) to Neutral
- Cannonball Research Starts Zapata Computing (ZPTA) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
